ProfoundBio raised $112 million to support development of its pipeline of antibody-drug conjugates (ADCs), agents that recognize a molecular target via… Read More
Don't miss a headline!
Sign up for GeekWire's newsletters today.
Thanks for subscribing!
Check your inbox to confirm your subscription.
